VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
1-Year Return
23.01%
This Quarter Return
+5.59%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$169M
AUM Growth
-$13M
(-7.2%)
Cap. Flow
-$16.1M
Cap. Flow
% of AUM
-9.55%
Top 10 Holdings %
Top 10 Hldgs %
6.26%
Holding
495
New
55
Increased
122
Reduced
257
Closed
60
Top Buys
| 1 |
NVIDIA
NVDA
|
$1.21M |
| 2 |
Netflix
NFLX
|
$1.05M |
| 3 |
Meta Platforms (Facebook)
META
|
$1.04M |
| 4 |
Adobe
ADBE
|
$995K |
| 5 |
Applied Materials
AMAT
|
$977K |
Top Sells
| 1 |
ATVI
Activision Blizzard Inc.
ATVI
|
$1.01M |
| 2 |
Progressive
PGR
|
$999K |
| 3 |
Stryker
SYK
|
$984K |
| 4 |
Republic Services
RSG
|
$973K |
| 5 |
Linde
LIN
|
$966K |
Sector Composition
| 1 | Healthcare | 27.98% |
| 2 | Technology | 15.96% |
| 3 | Financials | 11.34% |
| 4 | Energy | 8.43% |
| 5 | Industrials | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OXLC
126
Oxford Lane Capital
OXLC
$1.75B
| $533K | 0.32% |
110,110
-9,664
| -8% | -$46.8K |
|
127
Goldman Sachs BDC
GSBD
$1.31B
| $478K | 0.28% |
34,519
+6,368
| +23% | +$88.3K |
|
128
TriplePoint Venture Growth BDC
TPVG
$275M
| $478K | 0.28% |
40,585
+462
| +1% | +$5.44K |
|
|
XFLT
129
XAI Octagon Floating Rate and Alternative Income Trust
XFLT
$426M
| $452K | 0.27% |
67,717
-9,328
| -12% | -$62.3K |
|
130
Nuveen Credit Strategies Income Fund
JQC
$746M
| $445K | 0.26% |
88,213
-12,470
| -12% | -$63K |
|
131
Crescent Capital BDC
CCAP
$591M
| $432K | 0.26% |
28,545
-4,979
| -15% | -$75.4K |
|
132
WhiteHorse Finance
WHF
$204M
| $427K | 0.25% |
33,285
-2,469
| -7% | -$31.7K |
|
133
FS KKR Capital
FSK
$5.08B
| $421K | 0.25% |
21,946
-2,648
| -11% | -$50.8K |
|
134
MidCap Financial Investment
MFIC
$1.22B
| $406K | 0.24% |
32,337
-7,633
| -19% | -$95.9K |
|
135
Braskem
BAK
$1.41B
| $402K | 0.24% |
34,471
+2,224
| +7% | +$25.9K |
|
136
Bain Capital Specialty
BCSF
$1.02B
| $395K | 0.23% |
29,208
-5,248
| -15% | -$70.9K |
|
137
BlackRock TCP Capital
TCPC
$616M
| $392K | 0.23% |
35,933
+8,617
| +32% | +$94K |
|
138
SLR Investment Corp
SLRC
$911M
| $390K | 0.23% |
27,314
-5,189
| -16% | -$74K |
|
|
ECC
139
Eagle Point Credit Co
ECC
$954M
| $389K | 0.23% |
38,267
-22,942
| -37% | -$233K |
|
140
Agios Pharmaceuticals
AGIO
$2.09B
| $378K | 0.22% |
13,355
+3,423
| +34% | +$96.9K |
|
141
Halozyme
HALO
$8.76B
| $376K | 0.22% |
10,422
+5,160
| +98% | +$186K |
|
142
Insmed
INSM
$30.7B
| $376K | 0.22% |
17,814
+2,408
| +16% | +$50.8K |
|
|
BPMC
143
DELISTED
Blueprint Medicines
BPMC
| $370K | 0.22% |
5,848
-745
| -11% | -$47.1K |
|
|
IMGN
144
DELISTED
Immunogen Inc
IMGN
| $366K | 0.22% |
19,392
-40,181
| -67% | -$758K |
|
|
FCT
145
First Trust Senior Floating Rate Income Fund II
FCT
$263M
| $366K | 0.22% |
36,940
-6,149
| -14% | -$60.9K |
|
146
Vanda Pharmaceuticals
VNDA
$272M
| $361K | 0.21% |
54,805
+12,265
| +29% | +$80.8K |
|
147
Capital Southwest
CSWC
$1.28B
| $361K | 0.21% |
18,296
-7,132
| -28% | -$141K |
|
148
Roivant Sciences
ROIV
$8.82B
| $357K | 0.21% |
35,389
-7,271
| -17% | -$73.3K |
|
149
Immunocore
IMCR
$1.87B
| $357K | 0.21% |
5,949
+722
| +14% | +$43.3K |
|
150
Prospect Capital
PSEC
$1.34B
| $355K | 0.21% |
57,223
+5,139
| +10% | +$31.9K |
|